טוען...
Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599
PURPOSE: Human tuberculosis (TB) is a global health problem that causes nearly 2 million deaths per year. Anti-TB therapy exists, but it needs to be administered as a cocktail of antibiotics for six months. This lengthy therapy results in low patient compliance and is the main reason attributable to...
שמור ב:
| הוצא לאור ב: | Pharm Res |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7851762/ https://ncbi.nlm.nih.gov/pubmed/31321552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-019-2666-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|